Temasek Holdings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Temasek Holdings’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,240,000	Closed	-$147M	–	106
2021 Q1	$147M	Hold	1,240,000	–	–	0.58%	30
2020 Q4	$146M	Hold	1,240,000	–	–	0.63%	29
2020 Q3	$138M	Hold	1,240,000	–	–	0.7%	25
2020 Q2	$127M	Buy	1,240,000 +250,000	+25%	+$26.8M	0.76%	22
2020 Q1	$107M	Hold	990,000	–	–	0.79%	22
2019 Q4	$115M	Hold	990,000	–	–	0.75%	24
2019 Q3	$113M	Hold	990,000	–	–	0.83%	23
2019 Q2	$94.3M	Hold	990,000	–	–	0.67%	27
2019 Q1	$90.3M	Hold	990,000	–	–	0.63%	27
2018 Q4	$75.2M	Hold	990,000	–	–	0.52%	32
2018 Q3	$79.2M	Hold	990,000	–	–	0.46%	37
2018 Q2	$98.3M	Hold	990,000	–	–	0.52%	32
2018 Q1	$80.2M	Hold	990,000	–	–	0.44%	32
2017 Q4	$78M	Buy	990,000 +953,005	+2,576%	+$79.2M	0.48%	31
2017 Q3	$3.41M	Buy	+36,995	New	+$3.56M	0.02%	55

Temasek Holdings's CBPO Position: Q2 2021 in Review

Temasek Holdings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 1,240,000 shares — an estimated $147M sold.

Temasek Holdings first reported a position in CBPO in Q3 2017 and held it in 15 quarters. The position peaked at $147M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Temasek Holdings reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Temasek Holdings sold 1,240,000 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $147M.
Temasek Holdings first reported a position in China Biologic Products Holdings, Inc. in Q3 2017 and held it in 15 quarters.
Temasek Holdings's China Biologic Products Holdings, Inc. position peaked at $147M in Q1 2021.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Temasek Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.